Citigroup Inc Gilead Sciences, Inc. Put Options Transaction History

Citigroup Inc

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $4.81 Million - $6.06 Million	-72,200 Reduced 27.36%	191,700 $16.1 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $6.78 Million - $7.83 Million	107,400 Added 68.63%	263,900 $18.1 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $15.6 Million - $19 Million	-218,000 Reduced 58.21%	156,500 $11.5 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $7.33 Million - $8.31 Million	-100,000 Reduced 21.07%	374,500 $30.3 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $17.5 Million - $19.1 Million	237,000 Added 99.79%	474,500 $35.6 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $2.28 Million - $2.6 Million	30,000 Added 14.46%	237,500 $18.3 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $38.8 Million - $44.2 Million	-501,500 Reduced 70.73%	207,500 $17.2 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $9.35 Million - $13.4 Million	-150,000 Reduced 17.46%	709,000 $60.9 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $3.72 Million - $4.25 Million	62,500 Added 7.85%	859,000 $53 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $21.8 Million - $24.5 Million	-377,500 Reduced 32.16%	796,500 $49.2 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $27.8 Million - $34.8 Million	-480,000 Reduced 29.02%	1,174,000 $69.8 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $67.8 Million - $77 Million	1,045,000 Added 171.59%	1,654,000 $120 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $41.2 Million - $44.5 Million	609,000 New	609,000 $42.5 Million

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.